Most cannabis supplied by the U.S. government for research has less than 10% THC and may be over a year old.
Unbalanced cannabinoid tone appears to play a role in chronic kidney disease.
New developments in CBD genetics are about to shake up the cannabis industry.
Sometimes it’s best to combine CBD with conventional anti-epileptic meds.
Discover the clinical and laboratory research on THCA for epilepsy, chronic pain, digestive disorders, and more.
A cutting edge paper discusses the applications of cannabis for epilepsy and seizure disorders.
Both milk thistle and cannabis convey therapeutic benefits that are mediated by the endocannabinoid system.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.